article thumbnail

DEA Approves Cocaine Derivative for Parkinson’s Research. Why Not Cannabis?

Veriheal

As cannabis enthusiasts, we’re all too familiar with the stigma surrounding its use and the hoops that have to be jumped through to get it into medical research trials. But recent news of the DEA’s approval of a cocaine derivative for Parkinson’s disease research has left us scratching our heads. So what gives?

DEA 98
article thumbnail

DEA Assisting “to the Maximum Extent Possible” in the Federal Law Enforcement Response to Nationwide Protests — NORML Responds

NORML

According to a DEA memorandum , the agency requested to expand its policing powers beyond the enforcement of federal drug laws to include the enforcement of “any federal crime committed as a result of protests over the death of George Floyd.” The DEA possesses the power to strictly enforce these violations of law.

DEA 261
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

NIDA Monopoly is Over: New DEA-Registered Cannabis Growers Can Supply Researchers with Product

Cannabis Law Report

Drug Enforcement Agency (DEA) to cultivate marijuana for research purposes. In 2016, Dr. Sue Sisley first applied to grow cannabis for research purposes when the Obama administration announced a plan to allow other growers to provide cannabis to researchers. Nor are they limited to manufacturing whole-plant cannabis.

DEA 52
article thumbnail

Cancer Patients Sue the DEA, Demand Psilocybin

SpeedWeed

CANNABIS CULTURE – Attorney Kathryn Tucker, who filed the petition said this is a first-of-its-kind lawsuit. In January of 2021, Tucker wrote a letter to the DEA asking for access to psilocybin under the Right to Try (RTT) Act, which was designed for terminally ill patients who do not have time to wait for drug approval.

DEA 52
article thumbnail

DEA Reports Southern Border Pot Busts Down 80% Since 2013

SpeedWeed

In the 2020 National Drug Threat Assessment , which was released by the DEA on Wednesday, the agency notes that despite its continued illegality under federal law, marijuana “is the most commonly used illicit drug in the United States.”. This has led to the saturation of some markets, particularly in states that have legalized cannabis.

DEA 52
article thumbnail

Vicente Sederberg LLP Attorney Shane Pennington Elected to International Cannabis Bar Association Board of Directors

Cannabis Law Report

Pennington, who focuses on federal appeals and regulatory issues, is co-counsel on several high-profile cases against the DEA regarding cannabis research, hemp, and psychedelics. The INCBA supports lawyers in their practice of law as they serve all aspects of the cannabis and related industries. Hemp Industries Association v.

DEA 111
article thumbnail

Legislation To Produce And Research Cannabis Introduced

NORML

A bipartisan coalition of House lawmakers has introduced The Medical Cannabis Research Act of 2019 ( HR 601 ), to facilitate federally-approved clinical trials involving cannabis. Click here to send a message to your Representative and urge them to support the measure. . The agency ultimately rejected her decision.